# â­ [Tier A] Genetic Mutation-Disease Association Dataset

**Paper**: https://www.semanticscholar.org/paper/bf966bad177e2c752140251a979769a3a3e95c4b
**Published**: 2025-06-15
**Citations**: 3
**Source**: semantic_scholar

---

## ğŸ’° Business Opportunity

The dataset created from this research could be valuable for pharmaceutical companies, biotech startups, and academic researchers working on developing new treatments for genetic diseases. It provides a comprehensive and well-validated dataset linking genetic mutations to their disease associations, stability changes, and solubility alterations.

**Target Customers**: Pharmaceutical companies, biotech startups, academic research institutions, and organizations focused on precision medicine and genetic disease research.
**Market Gap**: There is a growing need for high-quality, curated datasets that can aid in the development of new drugs and therapies targeting genetic diseases. Currently available datasets may lack interpretability or fail to capture the complex physical and chemical interactions underlying genetic mutations.

---

## ğŸ“Š Scoring

**Value Score**: 7.5/10
**Confidence**: 7.0/10
**Tier**: A

**Enhanced Dimensions**:
- Data Efficiency: 7.5/10
- Source Quality: 8.0/10
- Generalizability: 7.0/10

**Signals Detected**:
- Performance: 10.0


---
## âš ï¸ Concerns

Ensuring the dataset is regularly updated and maintained to keep up with the rapidly evolving understanding of genetic mutations and their impacts. Potential challenges in scaling the data collection and validation processes.

---

*Detected: 2025-11-13 23:11:31 UTC*
*Finding ID: rdla_20251113_231131*
